Michael Braun

Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer

Scott Kopetz, Axel Grothey, Rona Yaeger et al. · New England Journal of Medicine · 2019 · 1.4K citations · Full text

Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial

Michael Braun, Susan D. Richman, Philip Quirke et al. · Journal of Clinical Oncology · 2008 · 275 citations · Full text

Functional Outcome Following Stroke Thrombectomy in Clinical Practice

Frank A. Wollenweber, Steffen Tiedt, Anna Alegiani et al. · Stroke · 2019 · 244 citations · Full text

Prevalence of <i>BRCA1/2</i> germline mutations in 21 401 families with breast and ovarian cancer

Karin Kast, Kerstin Rhiem, Barbara Wappenschmidt et al. · Journal of Medical Genetics · 2016 · 217 citations

Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response

Sibylle Loibl, Jens Huober, Michael Braun et al. · Annals of Oncology · 2022 · 212 citations

Neoadjuvant Durvalumab, Breast Oncology, Medicine +8